Argutus Medical, a developer of specialised organ injury tests, and a subsidiary of EKF Diagnostics, has introduced RenaStat, its new point-of-care (POC) test.RenaStat was specifically developed to detect the early onset of severe acute kidney injury (AKI) in critical care settings.
The Argutus team can also provide scientific information on the development and use of biomarkers for AKI detection.
www.argutusmed.com
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
10 Union Street, London, SE1 1SZ
2 March, 2026
Online
3-4 March, 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
Online
10-11 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026
